Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma.

Cancer chemotherapy and pharmacology

Volumn 57, Issue 1, 2006, Pages 105-113

  Bierau, Jörgen ^a   van Gennip, Albert H ^a   Leen, René ^a   Meinsma, Rutger ^a   Caron, Huib N ^a   van Kuilenburg, André B P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPENTENYL CYTOSINE; CYTIDINE; DEOXYCYTIDINE; DEOXYCYTIDINE KINASE; DRUG DERIVATIVE; GEMCITABINE; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOBLOTTING; METABOLISM; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CYTIDINE; DEOXYCYTIDINE; DEOXYCYTIDINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME ACTIVATION; HUMANS; IMMUNOBLOTTING; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS;

EID: 33644672583     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0005-8     Document Type: Article

References (0)